Abaloparatide vs TB-500

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Abaloparatide and TB-500 are both bone & joint peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares Abaloparatide and TB-500 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

AbaloparatideTB-500
CategoryBone & JointBone & Joint
Regulatory status (US)Research use onlyCompounding (Rx) — Apr 2026
Typical dosage80 mcg2-5 mg
Frequencydailyweekly
Reported benefitsBone building, osteoporosis treatment, reduced fracture riskBone healing, joint mobility, connective tissue support
Reported side effectsSimilar to teriparatide but milderWell-tolerated

Key differences

Primary use. Abaloparatide is categorised under Bone & Joint, while TB-500 falls under Bone & Joint. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. Abaloparatide: not FDA-approved; treated as a research compound. TB-500: not FDA-approved; compounding permitted with a prescription as of April 2026.

Dosing. Abaloparatide is typically dosed at 80 mcg (daily). TB-500 is typically dosed at 2-5 mg (weekly).

Can you stack them?

Some protocols combine peptides, but stacking Abaloparatide and TB-500 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Abaloparatide and TB-500?
Abaloparatide and TB-500 are both bone & joint peptides, but they differ in mechanism, dosing, and regulatory status. Abaloparatide is not FDA-approved; generally classified as a research compound, whereas TB-500 is not FDA-approved; compounding permitted with a prescription (as of April 2026).
What is Abaloparatide used for?
Advanced bone anabolic.
What is TB-500 used for?
Connective tissue repair.
Can you take Abaloparatide and TB-500 together?
Some users combine peptides within a single protocol, but stacking Abaloparatide and TB-500 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Abaloparatide or TB-500 FDA-approved?
Abaloparatide is not FDA-approved; generally classified as a research compound. TB-500 is not FDA-approved; compounding permitted with a prescription (as of April 2026).

Read the full articles

  • Abaloparatide — full monograph: mechanism, research, dosing & references
  • TB-500 — full monograph: mechanism, research, dosing & references

More Bone & Joint comparisons

← All peptide comparisons